{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02331134",
      "OrgStudyIdInfo": {
        "OrgStudyId": "14-0842.cc"
      },
      "Organization": {
        "OrgFullName": "University of Colorado, Denver",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer",
      "OfficialTitle": "Pilot Study of Tissue and Hematopoietic/Mesenchymal Stem Cell Collection for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2021",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "May 13, 2015",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "February 2022",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "March 2022",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "December 26, 2014",
      "StudyFirstSubmitQCDate": "December 26, 2014",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "January 6, 2015",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "March 18, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "March 22, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "University of Colorado, Denver",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Karsh Family Research Fund",
            "CollaboratorClass": "UNKNOWN"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "The overall goal of this study is to develop a pre-clinical platform of melanoma and head and neck squamous cell cancer that will allow the investigators to learn more about these diseases and discover better and more individualized treatments.",
      "DetailedDescription": "The main objective of this study is to establish a humanized animal model. Investigators will consent patients who have melanoma and head and neck squamous cell cancer (HNSCC) and agree to take part in this research study. They will obtain peripheral hematopoietic stem cells (HSC), blood and tumor tissue at baseline from blood and tumor samples from these patients for use in establishing tumor explants in humanized mice. Therapy results on humanized mice will be correlated with existing or newly acquired efficacy results from those same immune-based or other therapies in patients. A secondary objective is to identify pharmacodynamic markers associated with each drug and biomarkers for evidence of efficacy or lack of thereof. Where possible, subjects receiving therapy with FDA-approved drugs of interest will be asked to provide sequential blood and tumor biopsies to study the molecular and immune events that may occur as a result of drug therapy."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Malignant Melanoma",
          "Head and Neck Cancer"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Tissue",
          "Hematopoietic Stem Cell",
          "Melanoma",
          "Squamous Head and Neck Cancer"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Not Applicable"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Basic Science",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "20",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Melanoma, head and neck",
            "ArmGroupType": "Other",
            "ArmGroupDescription": "10 μg/kg/day of Filgrastim will be given subcutaneously for 4 days",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Filgrastim"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Drug",
            "InterventionName": "Filgrastim",
            "InterventionDescription": "Patients will receive 10 μg/kg/day of filgrastim subcutaneously in a 4-day mobilization schedule",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Melanoma, head and neck"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Neupogen"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Tissue and Hematopoietic Stem Cell Collection",
            "PrimaryOutcomeDescription": "Tissue and hematopoietic/mesenchymal stem cell will be collected from patients with melanoma and squamous head and neck cancer. These will be used to establish humanized animal model.",
            "PrimaryOutcomeTimeFrame": "At the time of sample collection"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Identify pharmacodynamic markers",
            "SecondaryOutcomeDescription": "Patients receiving therapy with Food and Drug Administration (FDA) approved drugs of interest will be asked to provide sequential blood and tumor biopsies to study the molecular and immune events occurring as a result of therapy",
            "SecondaryOutcomeTimeFrame": "Up to 6 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nBiopsy proven incurable melanoma or incurable HNSCC amenable to have biopsy and/or surgical resection of either the primary and/or locoregional metastatic site, at the University of Colorado Hospital.\nAge ≥ 21 years old per NCI/NIH guidelines\nEastern Cooperative Oncology Group (ECOG) performance status of 0. 1, or 2\n\nAdequate bone marrow, hepatic and renal function:\n\nAbsolute neutrophil count ≥ 1,500/µL.\nPlatelets ≥ 100,000/µL.\nHemoglobin ≥ 9.0 g/dL.\nCreatinine ≤ 1.5x upper limit of normal (ULN) or calculated creatinine clearance ≥ 60 mL/min.\nTotal bilirubin ≤ 1.5x ULN.\nAspartate Aminotransferase (AST)/Alanine Aminotransferase ( ALT) ≤ 2x ULN.\nMeasurable disease according to Response Criteria in Solid Tumors (RECIST) version 1.1.\nO2 saturation ≥= 93% at room air.\nAbility to understand and willingness to sign a written informed consent document\n\nExclusion Criteria:\n\nContraindication (absolute or relative) to granulocyte colony-stimulating factor (G-CSF) filgrastim usage:\n\nknown hypersensitivity to E coli-derived proteins' filgrastim, or any other component of the product.\nSickle cell disorders.\nClinically significant and active lung hemorrhagic or inflammatory disease, including but not limited to chronic obstructive pulmonary disease (COPD), autoimmune disease, and alveolar hemorrhage; or hypoxemia of any etiology requiring oxygen.\nClinically significant splenomegaly or splenic metastases; history of splenic rupture, recent splenic trauma or other clinically significant splenic disease that increases the risk of splenic rupture.\nClinically significant and active malignancy other than incurable melanoma or head and neck squamous cell cancer.\nKnown hepatitis B or C, or HIV.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Brian Dauner",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "720-848-0052",
            "CentralContactEMail": "brian.dauner@ucdenver.edu"
          },
          {
            "CentralContactName": "Amy Wallace",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "720-848-2538",
            "CentralContactEMail": "amy.wallace@ucdenver.edu"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Antonio Jimeno, MD, PhD",
            "OverallOfficialAffiliation": "University of Colorado, Denver",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "University of Colorado Cancer Center",
            "LocationStatus": "Recruiting",
            "LocationCity": "Aurora",
            "LocationState": "Colorado",
            "LocationZip": "80045",
            "LocationCountry": "United States",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Brian Dauner",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "303-848-0052",
                  "LocationContactEMail": "brian.dauner@ucdenver.edu"
                }
              ]
            }
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000008545",
            "ConditionMeshTerm": "Melanoma"
          },
          {
            "ConditionMeshId": "D000006258",
            "ConditionMeshTerm": "Head and Neck Neoplasms"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000018358",
            "ConditionAncestorTerm": "Neuroendocrine Tumors"
          },
          {
            "ConditionAncestorId": "D000017599",
            "ConditionAncestorTerm": "Neuroectodermal Tumors"
          },
          {
            "ConditionAncestorId": "D000009373",
            "ConditionAncestorTerm": "Neoplasms, Germ Cell and Embryonal"
          },
          {
            "ConditionAncestorId": "D000009370",
            "ConditionAncestorTerm": "Neoplasms by Histologic Type"
          },
          {
            "ConditionAncestorId": "D000009369",
            "ConditionAncestorTerm": "Neoplasms"
          },
          {
            "ConditionAncestorId": "D000009380",
            "ConditionAncestorTerm": "Neoplasms, Nerve Tissue"
          },
          {
            "ConditionAncestorId": "D000018326",
            "ConditionAncestorTerm": "Nevi and Melanomas"
          },
          {
            "ConditionAncestorId": "D000009371",
            "ConditionAncestorTerm": "Neoplasms by Site"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M10680",
            "ConditionBrowseLeafName": "Melanoma",
            "ConditionBrowseLeafAsFound": "Melanoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M8500",
            "ConditionBrowseLeafName": "Head and Neck Neoplasms",
            "ConditionBrowseLeafAsFound": "Head and Neck Cancer",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M19648",
            "ConditionBrowseLeafName": "Neuroendocrine Tumors",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M18997",
            "ConditionBrowseLeafName": "Neuroectodermal Tumors",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M19540",
            "ConditionBrowseLeafName": "Neuroectodermal Tumors, Primitive",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11470",
            "ConditionBrowseLeafName": "Neoplasms, Germ Cell and Embryonal",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11467",
            "ConditionBrowseLeafName": "Neoplasms by Histologic Type",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11477",
            "ConditionBrowseLeafName": "Neoplasms, Nerve Tissue",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11598",
            "ConditionBrowseLeafName": "Nevus",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11600",
            "ConditionBrowseLeafName": "Nevus, Pigmented",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M19623",
            "ConditionBrowseLeafName": "Nevi and Melanomas",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T4091",
            "ConditionBrowseLeafName": "Neuroendocrine Tumor",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T4092",
            "ConditionBrowseLeafName": "Neuroepithelioma",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC04",
            "ConditionBrowseBranchName": "Neoplasms"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionMeshList": {
        "InterventionMesh": [
          {
            "InterventionMeshId": "D000078224",
            "InterventionMeshTerm": "Lenograstim"
          }
        ]
      },
      "InterventionAncestorList": {
        "InterventionAncestor": [
          {
            "InterventionAncestorId": "D000000276",
            "InterventionAncestorTerm": "Adjuvants, Immunologic"
          },
          {
            "InterventionAncestorId": "D000007155",
            "InterventionAncestorTerm": "Immunologic Factors"
          },
          {
            "InterventionAncestorId": "D000045505",
            "InterventionAncestorTerm": "Physiological Effects of Drugs"
          }
        ]
      },
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M1945",
            "InterventionBrowseLeafName": "Lenograstim",
            "InterventionBrowseLeafAsFound": "Vitamin",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M2780",
            "InterventionBrowseLeafName": "Adjuvants, Immunologic",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M9353",
            "InterventionBrowseLeafName": "Immunologic Factors",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}